Ellington Management Group’s Chemed CHE Stock Holding History

Ellington Management Group’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-700	Closed	-$292K	–	545
2019 Q3	$292K	Buy	+700	New	+$286K	0.05%	378
2018 Q1	–	Sell	-900	Closed	-$219K	–	835
2017 Q4	$219K	Buy	+900	New	+$204K	0.04%	459
2017 Q3	–	Sell	-1,500	Closed	-$307K	–	657
2017 Q2	$307K	Buy	+1,500	New	+$299K	0.04%	386
2015 Q2	–	Sell	-11,500	Closed	-$1.37M	–	707
2015 Q1	$1.37M	Buy	+11,500	New	+$1.28M	0.28%	79
2014 Q4	–	Sell	-3,800	Closed	-$391K	–	565
2014 Q3	$391K	Buy	+3,800	New	+$385K	0.27%	94
2013 Q4	–	Sell	-18,100	Closed	-$1.29M	–	589
2013 Q3	$1.29M	Buy	18,100 +15,100	+503%	+$1.07M	0.24%	78
2013 Q2	$217K	Buy	+3,000	New	+$220K	0.04%	652

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Ellington Management Group's CHE Position: Q4 2019 in Review

Ellington Management Group sold out of Chemed (CHE) in Q4 2019, closing a stake of 700 shares — an estimated $292K sold.

Ellington Management Group first reported a position in CHE in Q2 2013 and held it in 7 quarters. The position peaked at $1.37M in Q1 2015. 415 funds tracked by Wall St. Rank hold CHE as of Q4 2019.

Ellington Management Group reported no remaining Chemed position as of Q4 2019 after selling out during the quarter.
Ellington Management Group sold 700 Chemed shares in Q4 2019, an estimated $292K.
Ellington Management Group first reported a position in Chemed in Q2 2013 and held it in 7 quarters.
Ellington Management Group's Chemed position peaked at $1.37M in Q1 2015.
415 funds tracked by Wall St. Rank held Chemed as of Q4 2019.

Based on Ellington Management Group's 13F filing for Q4 2019, filed 14 Feb 2020.